Literature DB >> 22956728

Cervical cancer burden and prevention activities in Europe.

Vesna Kesic1, Mario Poljak, Svetlana Rogovskaya.   

Abstract

Cervical cancer is an important public health care problem in Europe. The overall incidence rate of cervical cancer in Europe is 10.6 per 100,000. However, within Europe, the incidence rates significantly differ, being lower in Western Europe where prevention programs are better developed. Significantly higher are the incidence and mortality rates in Central and Eastern Europe, being in close correlation to the intensity of organized screening. Human papillomavirus (HPV) vaccines are being delivered to the low-incidence populations that already have extensive screening programs, whereas the high-incidence countries have not implemented the vaccination programs yet. The resolution of the problem of cervical cancer control in Europe will be a matter of the implementation of public health care programs across the whole continent. ©2012 AACR

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956728     DOI: 10.1158/1055-9965.EPI-12-0181

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

1.  HOTAIR enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer.

Authors:  Li Jing; Wang Yuan; Dong Ruofan; Yu Jinjin; Qiu Haifeng
Journal:  Tumour Biol       Date:  2014-12-31

Review 2.  Epidemiology of HPV Related Malignancies.

Authors:  Nicholas Scott-Wittenborn; Carole Fakhry
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

3.  Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.

Authors:  Zhenjie Yang; Juan Liu; Qing Wang
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

4.  The education gradient in cancer screening participation: a consistent phenomenon across Europe?

Authors:  Barbara Willems; Piet Bracke
Journal:  Int J Public Health       Date:  2017-10-23       Impact factor: 3.380

5.  Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.

Authors:  Petr Kuglik; Jan Smetana; Vladimira Vallova; Lucie Moukova; Katerina Kasikova; Michaela Cvanova; Lucie Brozova
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 6.  The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.

Authors:  Denghua Pan; Kanglai Wei; Yanxin Ling; Shitao Su; Meilin Zhu; Gang Chen
Journal:  Med Sci Monit       Date:  2015-03-25

7.  Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study.

Authors:  Marta Trapero-Bertran; Amelia Acera Pérez; Silvia de Sanjosé; Josep Maria Manresa Domínguez; Diego Rodríguez Capriles; Ana Rodriguez Martinez; Josep Maria Bonet Simó; Norman Sanchez Sanchez; Pablo Hidalgo Valls; Mireia Díaz Sanchis
Journal:  BMC Public Health       Date:  2017-02-14       Impact factor: 3.295

8.  HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level.

Authors:  Emma Altobelli; Leonardo Rapacchietta; Valerio F Profeta; Roberto Fagnano
Journal:  Cancer Med       Date:  2019-04-16       Impact factor: 4.452

9.  Cancer incidence and mortality in Serbia 1999-2009.

Authors:  Jovan Mihajlović; Petros Pechlivanoglou; Marica Miladinov-Mikov; Snežana Zivković; Maarten J Postma
Journal:  BMC Cancer       Date:  2013-01-15       Impact factor: 4.430

Review 10.  Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies.

Authors:  Victoria Fernández de Casadevante; Julita Gil Cuesta; Lourdes Cantarero-Arévalo
Journal:  Front Oncol       Date:  2015-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.